Mayne Pharma Group Limited announced it has begun distribution of tacrolimus ointment, 0.1% in the United States. Tacrolimus ointment is a generic version of PROTOPIC®, indicated for the treatment of atopic dermatitis. According to IQVIA, the annual US market sales for tacrolimus ointment were USD 80 million for the twelve months ending November 20211. Mayne Pharma entered into a license and supply agreement with Sandoz AG to distribute tacrolimus ointment in non-retail channels.